Zoledronic and Urination - excessive volume - a phase IV clinical study of FDA data

Summary:

Urination - excessive volume is reported as a side effect among people who take Zoledronic (zoledronic acid), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Bicalutamide, and have Breast cancer.

The phase IV clinical study analyzes which people have Urination - excessive volume when taking Zoledronic. It is created by eHealthMe based on reports of 29,760 people who have side effects when taking Zoledronic from the FDA, and is updated regularly.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.

What is Urination - excessive volume?

Urination - excessive volume is found to be associated with 925 drugs and 1,309 conditions by eHealthMe. Check the latest studies of Urination - excessive volume.

On Jul, 14, 2026

29,760 people reported to have side effects when taking Zoledronic.
Among them, 33 people (0.11%) have Urination - excessive volume.

Could Zoledronic cause Urination - excessive volume?

Among these 33 people:

How long have people been on Zoledronic when they have Urination - excessive volume? *

What is the gender of people who have Urination - excessive volume when taking Zoledronic? *

female: 78.79 %
male: 21.21 %

What is the age of people who have Urination - excessive volume when taking Zoledronic? *

What are other drugs people take besides Zoledronic? *

Eligard: 5 people, 15.15%
Bicalutamide: 5 people, 15.15%
Alimta: 4 people, 12.12%
Palonosetron: 4 people, 12.12%
Oxycodone Hydrochloride: 4 people, 12.12%
Oxycodone: 4 people, 12.12%
Opdivo: 4 people, 12.12%
Dexamethasone Sodium Phosphate: 4 people, 12.12%
Sugammadex Sodium: 4 people, 12.12%
Pemetrexed: 4 people, 12.12%

What are other side effects people have besides Urination - excessive volume? *

Thirst - Excessive: 15 people, 45.45%
Osteonecrosis Of Jaw (death of bone of jaw): 9 people, 27.27%
Thirst: 9 people, 27.27%
Fever: 8 people, 24.24%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 8 people, 24.24%
Weakness: 8 people, 24.24%
Headache (pain in head): 7 people, 21.21%
Dry Mouth: 6 people, 18.18%
Bone Pain: 5 people, 15.15%
Metastases To Bone (cancer spreads to bone): 5 people, 15.15%

What are the existing conditions these people have? *

Prostate Cancer: 5 people, 15.15%
Breast Cancer: 5 people, 15.15%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 12.12%
Infection Susceptibility Increased: 4 people, 12.12%
Osteoporosis (bones weak and more likely to break): 3 people, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 9.09%
Breast Cancer Metastatic: 3 people, 9.09%
Non-Small Cell Lung Cancer Recurrent (type of epithelial lung cancer reoccurrence): 3 people, 9.09%
Hypoglycemia (low blood sugar): 3 people, 9.09%
Metastases To Bone (cancer spreads to bone): 3 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zoledronic and have Urination - excessive volume?

- Check whether Urination - excessive volume is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zoledronic:

Zoledronic (29,812 reports)

Browse all side effects of Zoledronic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urination - excessive volume:

Urination - excessive volume (925 drugs)

Browse all the conditions that are associated with Urination - excessive volume:

Urination - excessive volume (1,309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zoledronic acid (the active ingredients of Zoledronic) and Zoledronic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.